Q: State the diagnosis and treatment of plan A: I now have all the information needed to give a thorough answer. Here is my complete analysis: --- Case Analysis - Atal Institute of Medical Super Specialities, Shimla --- Clinical Summary from Case Sheet Patient: Male, 64 years, smoker, DM on oral hypoglycemics Chief Complaint: Chest pain - sudden onset at 6:30 PM on 19/6/26 while sleeping History of Present Illness: - Retrosternal, diffuse chest pain - Moderate to severe intensity - Radiating to the left arm - Associated with sweating, nausea/vomiting, palpitations, dizziness Past History: Went to Rampur, was thrombolysed twice at 9 PM QCS - IT? type noted; likely prior ACS event or same episode at another center before transfer Family History: Father - chest pain suggesting familial CAD Cardiovascular Risk Factors: - Smoking active smoker - Diabetes mellitus DM, on oral agents - Hypertension BP 140/80 - Family history of CAD - Dyslipidemia Lipids: Total cholesterol 199 / LDL 197 / HDL 39 / Triglycerides 122.5 - borderline dyslipidemia Examination Findings: - BP: 140/80 mmHg, PR: 80/min - CVS: Non-sustained, no pericardial rub, no thrills - RS: B/L equal air entry, clear - Nervous System: Plantar bilateral, WBC normal - ECG: NR normal rate? 76/pm; QS - V1-V5, ST elevation V4-V6, 5 aVL; Q waves III, II, aVR Echo findings noted: 1+ RVSR, trivial MR, IVC 18mm dilated - suggests elevated right atrial pressure, LVEF not clearly legible but likely reduced Lab values CBG 16/25/279 noted: Blood glucose elevated 279 consistent with DM NTG BNP - 718 elevated, consistent with heart failure/myocardial stress; Troponin - 9.0 markedly elevated --- DIAGNOSIS Primary Diagnosis: Acute ST-Elevation Myocardial Infarction STEMI - Anterior Wall Extensive - ECG: ST elevation in V4-V6, 5, aVL with QS pattern in V1-V5 = extensive anterior STEMI - Q waves in leads III, II, aVR suggest inferior involvement also possible or old infarct - Troponin: 9.0 markedly elevated, confirming myocardial necrosis - NT-proBNP: 718 elevated - suggests LV dysfunction / early heart failure - Classic presentation: retrosternal chest pain radiating to left arm, sweating, onset at rest Associated Diagnoses / Comorbidities: 1. Coronary Artery Disease CAD - underlying substrate 2. Type 2 Diabetes Mellitus - uncontrolled CBG 279 3. Hypertension - BP 140/80 4. Dyslipidemia - LDL 197 mg/dL high, HDL 39 low 5. Active Smoker 6. Mild LV dysfunction / early Killip Class II given elevated BNP, trivial MR, dilated IVC --- TREATMENT PLAN This patient has already received thrombolysis twice at Rampur before transfer. The current management at a super-specialty center should focus on: 1. Immediate / Emergency Management MONA + Antiplatelet Drug Dose Purpose --------------------- Aspirin 300 mg stat, then 75 mg OD Antiplatelet Clopidogrel since thrombolysed 300 mg loading, then 75 mg OD P2Y12 inhibitor preferred over ticagrelor/prasugrel post-fibrinolysis Enoxaparin LMWH 1 mg/kg SC BD Anticoagulation post-fibrinolysis Oxygen If SpO2 94% Hypoxia correction Nitroglycerin 0.4 mg SL / IV infusion Chest pain relief, preload reduction Morphine 2-4 mg IV if refractory pain Analgesia, catecholamine reduction Beta-blocker Metoprolol 25-50 mg PO Anti-ischemic, reduces arrhythmia risk only if HR/BP permits, no shock/HF 2. Reperfusion Strategy Since the patient was already thrombolysed: - Assess for signs of successful reperfusion: pain relief, 50% ST resolution at 60-90 min post-lysis - If reperfusion failed rescue PCI indication: persistent ST elevation, ongoing chest pain, hemodynamic instability - Urgent Coronary Angiography + Rescue PCI - If reperfusion successful: Plan pharmacoinvasive strategy - routine coronary angiography within 3-24 hours of successful thrombolysis per current guidelines Per the Washington Manual of Medical Therapeutics: "Patients who do not experience chest pain relief, have recurrent chest pain, have unstable arrhythmias, develop heart failure, or have ST-segment elevations that do not normalize 60-90 minutes following fibrinolysis should undergo rescue PCI." 3. Post-Reperfusion / Secondary Prevention Long-term Drug Purpose --------------- Dual antiplatelet therapy Aspirin + Clopidogrel x 1 year Post-ACS/stent High-intensity statin Atorvastatin 40-80 mg OD LDL target 70 mg/dL currently LDL 197 ACE inhibitor Ramipril 2.5-5 mg OD LV protection, mortality benefit Beta-blocker Carvedilol / Metoprolol Reduce mortality, prevent arrhythmia Aldosterone antagonist Eplerenone If EF 40% with symptoms of HF 4. Diabetes & BP Control - Target HbA1c 7%, optimize antidiabetic therapy avoid sulfonylureas acutely; insulin infusion if needed - Target BP 130/80 mmHg ACE inhibitor provides dual benefit 5. Monitoring - Serial ECGs Q1-2h initially - Continuous cardiac monitoring for arrhythmias VT/VF risk in first 48h - Serial troponins, serial echocardiography to assess LV function - Daily renal function, electrolytes especially if on ACE inhibitor + LMWH - Monitor blood glucose closely 6. Lifestyle & Rehabilitation - Strict smoking cessation most important modifiable risk factor - Cardiac rehabilitation program - Low-fat, low-salt, diabetic-friendly diet - Lipid counseling --- Summary Table Category Diagnosis / Plan --------------------------- Diagnosis Extensive Anterior STEMI V1-V6, aVL with Q waves Reperfusion done Thrombolysis x2 at Rampur - assess success Next step Coronary angiography ± rescue/pharmacoinvasive PCI Antiplatelets Aspirin + Clopidogrel dual therapy Anticoagulation Enoxaparin LMWH Cardiac protection Beta-blocker + ACE inhibitor + high-dose statin Comorbidities DM control + BP control + smoking cessation - Symptom to Diagnosis: An Evidence-Based Guide, 4th ed., p. 175 - Washington Manual of Medical Therapeutics, Acute Coronary Reperfusion, p. 155-156
